Argenta Technologies
Get to market faster with a validated, patent-protected drug delivery technology developed exclusively for veterinary use. License one of our three platforms for your molecule, with development, manufacturing, and regulatory support from the same team.
Talk to our formulation scientists
Up to 34% drug loading in our microspheres
343 days of controlled release from a single capsule
>85% full acceptability for our soft chews
Our Technologies
Reduce dosing frequency with biodegradable lipid microspheres that release your API over one week to 12 months. They’re small enough for standard syringe injection, and they mask bitter flavours in oral formulations.
Treat cattle and sheep for up to a year from a single administration, with zero-order release proven over 343 days and multiple APIs delivered from one device.
Give pets a dose they’ll take, with >85% full acceptability. Continuous low-temperature extrusion with no added water delivers tablet-level stability in a treat-like format for pharmaceutical and nutraceutical products.
Integrate your molecule with a platform that’s already validated, so you avoid the time and cost of developing a new dosage form in-house.
Fewer doses, better palatability, and simpler administration make treatment more reliable for pets, livestock, and the people caring for them.
Reformulate an existing molecule on a patent-protected platform to differentiate it and protect its place in the market.
Check compatibility, release profile options, and formulation strategy before you make a significant investment.
Optimise the platform for your API, target species, and therapeutic goals.
Compile your dossier with our in-house animal health regulatory team.
Manufacture at commercial scale in our GMP facilities.
Generating innovative product ideas and navigating product patent life extensions can be challenging. We elevate your drug development programmes with our proprietary delivery technologies. Customers can also license our technologies, integrating them with their existing molecules so they can accelerate their product lifecycle. With Argenta, faster innovation and growth is within reach.
Animal health is a thriving market, with copious opportunities for drug development companies to bring innovative products to market to meet the evolving needs of customers, and ensuring that the intellectual property of existing products is extended for as long as possible.
As patents expire, generic alternatives can enter the market, intensifying competition and potentially diminishing financial returns. Innovative drug delivery solutions and novel formulation chemistries can help you extend patent life, maximising revenue from each product line.
The animal health market is continually evolving, with pet and livestock owners seeking innovative healthcare products that are easier to administer and deliver better outcomes. Drug companies must increasingly look to new drug delivery technologies to keep up with customer needs.
Preserving customer interest and protecting market share requires new product ideas. However, creating new products using innovative dosage forms needs out-of-the-box thinking, deep technical expertise, and a strong understanding of customer needs.
At Argenta, we approach each project with an open mind and have the expertise and resources to create and apply innovative solutions that help our customers bring exciting new products and dosage forms to market.
Our Innovation team focuses on the development of novel drug delivery technologies, unique offerings and products that advance animal health. Our IP portfolio includes a range of novel drug delivery technologies.
We can tailor our technologies to create new therapeutics where improved product performance and end-user compliance is key. We’ve embraced a culture of creative problem-solving and collaboration with our customers, leading to many successful outcomes.
Licensable novel drug delivery technologies to accelerate product development or lifecycle projects.
Unique controlled-release intraruminal delivery system with the ability to combine a range of APIs in a single device.
Long-acting biodegradable microspheres for extended duration of action.
Versatile, palatable, water-free drug delivery platform.
Dry granule technology that rapidly disperses in water to produce customised, single, or combination therapeutics.
Simple non-aqueous solution utilising a highly effective permeation system.
From 'molecule to market', Argenta offers a comprehensive package of services to support your commercialisation goals. Wherever you are in your product development journey, we can help.
